Literature DB >> 21623574

Home dialysis first: a new paradigm for new ESRD patients.

Elias D Thodis1, Dimitrios G Oreopoulos.   

Abstract

Patients with end-stage renal disease (ESRD) were treated with either in-center hemodialysis (ICH) or one of the modes of home-based dialysis (HBD)-- peritoneal dialysis (PD) or home hemodialysis (HHD). Home-based dialysis modes showed better outcomes than ICH (PD for the first 2-3 years and HHD for the long-term). Home PD has become more attractive with overnight cyclers for PD and the use of home helpers. Home dialysis (PD or HHD) offers a high quality of life and a high degree of independence and is financially attractive. This review will propose a paradigm shift in the initial form of dialysis offered to new patients with ESRD: instead of selecting between in-center dialysis and PD, patients after they are advised of the advantages of dialysis at home (either PD or HHD) should be offered a choice between dialysis at home (PD or HHD) or in hospital. We will review the advantages of home-based dialysis and the arguments for this simple but vital change in the process by which new patients requiring dialysis choose their treatment option.

Entities:  

Mesh:

Year:  2011        PMID: 21623574     DOI: 10.5301/JN.2011.8374

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  8 in total

1.  Effect of oral ferric citrate on serum phosphorus in hemodialysis patients: multicenter, randomized, double-blind, placebo-controlled study.

Authors:  Chien-Te Lee; I-Wen Wu; Shou-Shan Chiang; Yu-Sen Peng; Kuo-Hsiung Shu; Ming-Ju Wu; Mai-Szu Wu
Journal:  J Nephrol       Date:  2014-05-20       Impact factor: 3.902

2.  Utility of Peritoneal Scintigraphy in Peritoneal Dialysis Patients: One Center Experience.

Authors:  R Haridian Sosa Barrios; María Eugenia Rioja Martín; Víctor Burguera Vion; Astrid Lucía Santos Carreño; Milagros Fernández Lucas; Maite E Rivera Gorrín
Journal:  Kidney360       Date:  2020-03-24

Review 3.  Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices.

Authors:  Bruce M Robinson; Tadao Akizawa; Kitty J Jager; Peter G Kerr; Rajiv Saran; Ronald L Pisoni
Journal:  Lancet       Date:  2016-05-22       Impact factor: 79.321

4.  Lifetime costs for peritoneal dialysis and hemodialysis in patients in Taiwan.

Authors:  Tze-Wah Kao; Yu-Yin Chang; Pau-Chung Chen; Chih-Cheng Hsu; Yu-Kang Chang; Yu-Hung Chang; Lukas Jyuhn-Hsiarn Lee; Kwan-Dun Wu; Tun-Jun Tsai; Jung-Der Wang
Journal:  Perit Dial Int       Date:  2013-05-01       Impact factor: 1.756

5.  The risk of hospitalization and modality failure with home dialysis.

Authors:  Rita S Suri; Lihua Li; Gihad E Nesrallah
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

6.  Attitudes of nephrologists towards assisted home dialysis in Germany.

Authors:  Wolfgang Pommer; Steffen Wagner; Dominik Müller; Julia Thumfart
Journal:  Clin Kidney J       Date:  2017-11-10

7.  Survival on home dialysis in New Zealand.

Authors:  Mark R Marshall; Rachael C Walker; Kevan R Polkinghorne; Kelvin L Lynn
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

8.  Comparative effectiveness of home dialysis therapies: a matched cohort study.

Authors:  Gihad E Nesrallah; Lihua Li; Rita S Suri
Journal:  Can J Kidney Health Dis       Date:  2016-03-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.